Baroreflex Activation Therapy and Subcutaneous ICDs

Key Result

Concurrent use of subcutaneous ICDs and baroreflex activation therapy is feasible with appropriate testing and output optimization.

Key Points

• The aim is to assess the feasibility of using baroreflex activation therapy alongside subcutaneous ICDs.
• Assess compatibility of baroreflex activation therapy with subcutaneous ICDs
• Optimize device output
• Conduct careful testing to ensure effectiveness
• Concurrent use of both therapies is feasible
• Output optimization is necessary for effective use
• Successful testing guidelines established for combined therapy